ASU Roybal Center
Our Mission
Living alone has emerged as a risk factor for Alzheimer’s disease and related dementias (ADRD). A third of community-dwelling older adults with ADRD live alone, but there are limited interventions to help them live alone safely and for as long as they desire. The goal of the Arizona State University Roybal Center is to develop an infrastructure and conduct clinical trials of MoBC-driven, technology-enabled interventions to delay ADRD and improve quality of life (QoL) in older adults living alone with cognitive decline.
Learn about the NIA Roybal Centers
What is a Roybal Center?
The goal of the Roybal Center program is the translation and integration of basic behavioral and social research findings into interventions to improve the lives of older people and the capacity of institutions to adapt to societal aging. The National Institute on Aging’s Division of Behavioral and Social Research currently supports fifteen Roybal Centers, funded through RFA-AG-19-006 and
RFA-AG-19-007, as well as a Coordinating Center, funded through RFA-AG-19-008. Roybal Centers are structured within the conceptual framework of the multidirectional, translational NIH Stage Model to produce potent and implementable principle-driven behavioral interventions.
Read more about the Roybal Center program and its centers:
Current Funding Opportunities
ASU Roybal Center seeks applications to conduct NIH Stage I-IV randomized clinical trials that will develop and test mechanisms of behavioral change (MoBC)-driven and technology-enabled behavioral and lifestyle interventions for older adults living alone with cognitive decline. Four 2 year trials will be funded, with total funding up to $180,000 (direct + indirect costs) per trial. All awards expected to begin on June 1, 2026 (pending NIA approval). Applicants are strongly encouraged to seek indirect cost (IDC) waivers from their institutions to maximize available direct costs. A one-year no-cost extension may be considered.
These trials should test the ASU Roybal Center’s Conceptual Framework (Exhibit 1) with rigorous design to secure future funding (e.g.,NIH R01) to advance to the next Stage.